Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach crawled date : 2021 - 11 - 10 save search
Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs
Published: 2021-11-10 (Crawled : 23:00) - biospace.com/
OCX | News J | $2.495 -2.54% -2.61% 50K
|
Health Technology
|
| O: 0.29%
H: 3.77%
C: -2.9%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: -0.81%
H: 2.45%
C: -3.67%
financial results therapy results
GoodRx Releases Third Quarter 2021 Financial Results
Published: 2021-11-10 (Crawled : 23:00) - biospace.com/
GDRX 4 | $6.69 -0.59% -0.6% 640K
|
Technology Services
|
| O: -2.32%
H: 5.87%
C: 1.77%
financial results results
GT BioPharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-10 (Crawled : 23:00) - biospace.com/
GTBP | $3.8001 1.3% 5.9K
|
Manufacturing
|
| O: -1.3%
H: 6.02%
C: -2.44%
biopharma financial results results
PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
Published: 2021-11-10 (Crawled : 23:00) - biospace.com/
PHAS | $0.0701 -23.97%
|
Health Technology
|
| O: 2.61%
H: 1.13%
C: -2.54%
financial results results
Zentalis Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: -0.63%
H: 1.32%
C: -0.7%
financial results results
Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-10 (Crawled : 20:00) - biospace.com/
VIRX | $0.88 -3.19% -3.3% 53K
|
Manufacturing
|
| O: -0.68%
H: 1.53%
C: -3.4%
XOMA | News | $24.97 1.55% 1.52% 17K
|
Health Technology
|
| O: -0.39%
H: 5.98%
C: 3.15%
financial results results
Daré Bioscience Reports Third Quarter 2021 Financial Results and Provides a Company Update
Published: 2021-11-10 (Crawled : 18:00) - biospace.com/
DARE | $0.2838 -3.83% -3.98% 550K
|
Health Technology
|
| O: -2.38%
H: 3.66%
C: 2.44%
financial results results
PhaseBio Pharmaceuticals to Host Investor Call to Discuss Interim Results from Pivotal REVERSE-IT Phase 3 Trial Presented at the American Heart Association Annual Meeting
Published: 2021-11-10 (Crawled : 14:00) - biospace.com/
PHAS | $0.0701 -23.97%
|
Health Technology
|
| O: 2.61%
H: 1.13%
C: -2.54%
heart results phase 3 trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.